1. (a) All facilities shall respond to SCR requests for case information pursuant to He-P 304.02(b) and (c) within 14 working days of receipt of such requests.
2. (b) All facilities shall respond to SCR requests to perform a site visit.

3. (c) SCR shall perform a site visit at each facility in order to:

   1. (1) Audit pathology reports and other information to ensure that no cancer cases are overlooked in reporting; and
   2. (2) Monitor the completeness and accuracy of the cancer reports.

4. (d) Each facility shall make available for reviewing and copying all paper or electronically stored information including the following:

   1. (1) Laboratory analyses including tissue, cytology, and pathology reports;
   2. (2) Records regarding radiological examinations, in relation to cancer diagnoses or treatment;
   3. (3) Reports of diagnoses of malignant disease, and notations of the reasons for such diagnoses, including both primary clinicians’ reports and consultants’ reports;
   4. (4) Pharmacy records;
   5. (5) Reports regarding any operations or an autopsy;
   6. (6) Discharge plans and abstracts regarding cancer diagnoses; and
   7. (7) A list of the applicable discharge diagnoses or treatment as identified in the “Casefinding Lists, Current Lists/Code List,” (October 1, 2015-September 30, 2016), as listed in Appendix A and available as a free electronic document at http://seer.cancer.gov/tools/casefinding/case2016-icd10cm.html.
5. (e) Pursuant to 42 USC 280e(c)(2)(D)(viii), individuals complying with the law shall not be held liable in any civil action with respect to a report of cancer provided to the SCR, or with respect to access to data or information provided to the SCR.

Source. #4377, eff 3-1-88; ss by #5601, eff 3-24-93, EXPIRED: 3-24-99 New. #7406, eff 11-21-00; ss by #9046, eff 12-5-07; ss by #11054, eff 3-15-16